Literature DB >> 20931386

MicroRNA biogenesis and cancer.

Julia Winter1, Sven Diederichs.   

Abstract

MicroRNAs are short non-coding RNA molecules that are involved in diverse physiological and developmental processes by controlling the gene expression of target mRNAs. They play important roles in almost all kinds of cancer where they modulate key processes during tumorigenesis such as metastasis, apoptosis, proliferation, or angiogenesis. Depending on the mRNA targets they regulate, they can act as oncogenes or as tumor suppressor genes. Multiple links between microRNA biogenesis and cancer highlight its significance for tumor diseases. However, mechanisms of their own regulation on the transcriptional and posttranscriptional level in health and disease are only beginning to emerge. Here, we review the microRNA-processing pathway as well as recent insights into posttranscriptional regulation of microRNA expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20931386     DOI: 10.1007/978-1-60761-863-8_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  56 in total

Review 1.  Role of microRNAs in lymphoid biology and disease.

Authors:  Muller Fabbri; Carlo M Croce
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

2.  MicroRNA miR-1249 downregulates adenomatous polyposis coli 2 expression and promotes glioma cells proliferation.

Authors:  Baojun Fang; Guoliang Li; Chongfu Xu; Yuzuo Hui; Gang Li
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

3.  Polymorphisms in miRNA binding site: new insight into small cell lung cancer susceptibility.

Authors:  Hong-yu Liu; Jun Chen
Journal:  Acta Pharmacol Sin       Date:  2011-08-29       Impact factor: 6.150

Review 4.  miRNA-transcription factor interactions: a combinatorial regulation of gene expression.

Authors:  S Arora; R Rana; A Chhabra; A Jaiswal; V Rani
Journal:  Mol Genet Genomics       Date:  2013-01-20       Impact factor: 3.291

5.  Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer.

Authors:  Lyndsay V Rhodes; Syreeta L Tilghman; Stephen M Boue; Shuchun Wang; Hafez Khalili; Shannon E Muir; Melyssa R Bratton; Qiang Zhang; Guangdi Wang; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncol Lett       Date:  2011-10-24       Impact factor: 2.967

Review 6.  Molecular imaging of microRNAs.

Authors:  Fu Wang; Gang Niu; Xiaoyuan Chen; Feng Cao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-30       Impact factor: 9.236

7.  Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk.

Authors:  Robert S Chapkin; Vanessa DeClercq; Eunjoo Kim; Natividad Roberto Fuentes; Yang-Yi Fan
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

8.  Inhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia.

Authors:  Korosh Ashrafi Dehkordi; Morteza Hashemzadeh Chaleshtori; Mohamadreza Sharifi; Ali Jalili; Fardin Fathi; Daem Roshani; Bahram Nikkhoo; Mohammad Saeed Hakhamaneshi; Mohammad Reza Mahmoodian Sani; Mahboue Ganji-Arjenaki
Journal:  Indian J Hematol Blood Transfus       Date:  2016-06-17       Impact factor: 0.900

9.  MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Authors:  Martina Redova; Alexandr Poprach; Andrej Besse; Robert Iliev; Jana Nekvindova; Radek Lakomy; Lenka Radova; Marek Svoboda; Jan Dolezel; Rostislav Vyzula; Ondrej Slaby
Journal:  Tumour Biol       Date:  2012-11-13

Review 10.  Smoking and microRNA dysregulation: a cancerous combination.

Authors:  Navneet Momi; Sukhwinder Kaur; Satyanarayana Rachagani; Apar K Ganti; Surinder K Batra
Journal:  Trends Mol Med       Date:  2013-11-13       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.